TLCD3A and cervical cancer: The resulting growth curves show that FAM57A silencing leads to a substantial inhibition of the proliferation of all investigated cervical cancer cell lines when compared to control siRNA-treated cells (Figure 6a), further corroborating the pro-proliferative activity of FAM57A in cervical cancer cells.